Balance Sheet
Accumulated DepreciationAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReal Estate - GrossReal Estate - NetReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Preferred Shares (2017 - 2025)

Historic Preferred Shares for Global Medical REIT (GMRE-PA) over the last 9 years, with Q3 2025 value amounting to $75.0 million.

  • Global Medical REIT's Preferred Shares changed 0.0% to $75.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $75.0 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Global Medical REIT's Preferred Shares stood at $75.0 million, which was down 0.0% from $75.0 million recorded in Q2 2025.
  • Over the past 5 years, Global Medical REIT's Preferred Shares peaked at $75.0 million during Q1 2021, and registered a low of $75.0 million during Q1 2021.
  • For the 5-year period, Global Medical REIT's Preferred Shares averaged around $75.0 million, with its median value being $75.0 million (2021).
  • Data for Global Medical REIT's Preferred Shares shows a peak YoY increase of 0.0% (in 2021) and a maximum YoY decrease of 0.0% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Global Medical REIT's Preferred Shares stood at $75.0 million in 2021, then changed by 0.0% to $75.0 million in 2022, then changed by 0.0% to $75.0 million in 2023, then changed by 0.0% to $75.0 million in 2024, then changed by 0.0% to $75.0 million in 2025.
  • Its last three reported values are $75.0 million in Q3 2025, $75.0 million for Q2 2025, and $75.0 million during Q1 2025.